Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Universal Health Services, Inc.
UHS
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $9.4B
$158.33
▲ +5.15%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$140.08 - $246.33
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 18.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive national healthcare facility network
- Diversified service offerings
- Integrated management and administrative systems
- Strong reputation in behavioral and acute care
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising healthcare demand
Value
Deep value opportunity - significant discount to Healthcare Facilities peers
Momentum
Weak
-14.8% over 3m
Quality
Excellent
Excellent business quality
Dividend
Modest
0.53% yield
Smart-money signal
Who's buying UHS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 27, 2026
APR 27, 2026
Reported EPS of $5.62 vs $5.41 consensus (+3.9% surprise). Revenue of $4.5B vs $4.4B expected (+2.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+3.9%
Next: Jul 27, 2026
Revenue trend · last 8Q
—
—
+11%
+7%
+10%
+13%
+9%
+10%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$3.9B
$4.0B
$4.1B
$4.1B
$4.3B
$4.5B
$4.5B
$4.5B
Margins · last 8Q
Gross
14.6%
Operating
11.2%
Profit
7.8%
Wall Street consensus
8 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
$204.00
▲ +28.8% vs $158.33
Latest: Wells Fargo · $165.00 · Jun 1, 2026
7 analysts covering